A detailed history of Schroder Investment Management Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 2,661,844 shares of ABBV stock, worth $479 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
2,661,844
Previous 2,093,305 27.16%
Holding current value
$479 Million
Previous $359 Million 46.41%
% of portfolio
0.56%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $93.1 Million - $113 Million
568,539 Added 27.16%
2,661,844 $526 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $35.2 Million - $41.1 Million
227,534 Added 12.2%
2,093,305 $359 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $4.44 Million - $5.06 Million
-27,760 Reduced 1.47%
1,865,771 $340 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $8.39 Million - $9.44 Million
60,942 Added 3.33%
1,893,531 $293 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $48.4 Million - $56.1 Million
362,449 Added 24.65%
1,832,589 $273 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $5.52 Million - $6.86 Million
41,628 Added 2.91%
1,470,140 $198 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $16.1 Million - $18.5 Million
-111,087 Reduced 7.22%
1,428,512 $228 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $49.5 Million - $59.4 Million
-358,076 Reduced 18.87%
1,539,599 $249 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $15.7 Million - $18 Million
-116,660 Reduced 5.79%
1,897,675 $255 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $31.3 Million - $39.8 Million
227,618 Added 12.74%
2,014,335 $310 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $66.5 Million - $82.5 Million
-503,947 Reduced 22.0%
1,786,717 $293 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $31.1 Million - $39.4 Million
289,498 Added 14.47%
2,290,664 $310 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $22.4 Million - $25.4 Million
210,677 Added 11.77%
2,001,166 $216 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $3.75 Million - $4.18 Million
-35,634 Reduced 1.95%
1,790,489 $202 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $10.6 Million - $11.7 Million
103,972 Added 6.04%
1,826,123 $198 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $17.5 Million - $23.7 Million
-217,705 Reduced 11.22%
1,722,151 $185 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $6.01 Million - $7.06 Million
-69,980 Reduced 3.48%
1,939,856 $167 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $20.8 Million - $27.9 Million
-284,160 Reduced 12.39%
2,009,836 $197 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $30.8 Million - $46.7 Million
-477,402 Reduced 17.23%
2,293,996 $174 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $94 Million - $118 Million
-1,302,639 Reduced 31.97%
2,771,398 $245 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $46.5 Million - $55.9 Million
738,176 Added 22.13%
4,074,037 $305 Million
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $528,819 - $675,955
8,049 Added 0.24%
3,335,861 $243 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $49.8 Million - $58.7 Million
646,051 Added 24.09%
3,327,812 $268 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $25.3 Million - $31.2 Million
324,587 Added 13.77%
2,681,761 $247 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $10.9 Million - $12.1 Million
-122,786 Reduced 4.95%
2,357,174 $223 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $40.6 Million - $48 Million
451,903 Added 22.28%
2,479,960 $229 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $1.46 Million - $1.95 Million
-15,839 Reduced 0.77%
2,028,057 $192 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $14.1 Million - $15.4 Million
-156,890 Reduced 7.13%
2,043,896 $198 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $154 Million - $196 Million
2,200,786
2,200,786 $196 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.